Skip to main content
Premium Trial:

Request an Annual Quote

Inproteo Licenses Patent to Genentech

NEW YORK, Jan. 21 (GenomeWeb News) - Inproteo, formerly known as the Indiana Proteomics Consortium, announced today that it has licensed US Patent No. 4,569,794 to Genentech.


The deal covers a patent, and its foreign counterparts, that describes a fusion protein purification technique known commonly as "His Tag."


The license covers all uses of the technology for the life of the patents, Inproteo said in a statement. Financial details were not disclosed.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.